Correlation of EGFR and KRAS mutation status, response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and survival with histologic subtypes of adenocarcinoma of the lung Meeting Abstract


Authors: Hussain, S.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.; Pao, W.; Riely, G.; Rizvi, N.; Gomez, J. E.; Miller, V.
Abstract Title: Correlation of EGFR and KRAS mutation status, response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors and survival with histologic subtypes of adenocarcinoma of the lung
Meeting Title: 41st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 23
Issue: 16 Suppl.
Meeting Dates: 2005 May 13-17
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2005-06-01
Start Page: 640S
Language: English
ACCESSION: WOS:000230326604196
PROVIDER: wos
DOI: 10.1200/jco.2005.23.16_suppl.7080
Notes: --- - Meeting Abstract: 7080 - 41st Annual Meeting of the American-Society-of-Clinical-Oncology - MAY 13-17, 2005 - Orlando, FL - S - Part 1 - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jorge Gomez
    27 Gomez
  2. Sanaa Hussain
    16 Hussain
  3. William Pao
    141 Pao
  4. Naiyer A Rizvi
    166 Rizvi
  5. Vincent Miller
    270 Miller
  6. Marc Ladanyi
    1329 Ladanyi
  7. Gregory J Riely
    601 Riely
  8. Maureen F Zakowski
    289 Zakowski
  9. Mark Kris
    869 Kris